1. Home
  2. SMHI vs ABOS Comparison

SMHI vs ABOS Comparison

Compare SMHI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEACOR Marine Holdings Inc.

SMHI

SEACOR Marine Holdings Inc.

HOLD

Current Price

$7.70

Market Cap

207.0M

ML Signal

HOLD

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

HOLD

Current Price

$2.52

Market Cap

182.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMHI
ABOS
Founded
1989
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.0M
182.0M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
SMHI
ABOS
Price
$7.70
$2.52
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.00
AVG Volume (30 Days)
73.8K
292.3K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
62.41
N/A
EPS
N/A
N/A
Revenue
$173,783,000.00
N/A
Revenue This Year
$1.21
N/A
Revenue Next Year
$9.31
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.70
$1.00
52 Week High
$8.17
$3.60

Technical Indicators

Market Signals
Indicator
SMHI
ABOS
Relative Strength Index (RSI) 57.79 50.95
Support Level $6.91 $2.15
Resistance Level $7.90 $2.77
Average True Range (ATR) 0.33 0.14
MACD 0.04 0.03
Stochastic Oscillator 72.00 75.10

Price Performance

Historical Comparison
SMHI
ABOS

About SMHI SEACOR Marine Holdings Inc.

Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that (i) deliver cargo and personnel to offshore installations, including offshore wind farms, (ii) assist offshore operations for production and storage facilities, (iii) provide construction, well work-over, offshore wind farm installation and decommissioning support and (iv) carry and launch equipment used underwater in drilling and well installation, maintenance, inspection and repair. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America, with the majority of revenue deriving from the Africa and Europe segment.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.

Share on Social Networks: